Integrating Prostate-specific Antigen Kinetics into Contemporary
Integrating Prostate-specific Antigen Kinetics into Up to date Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy
Background: Salvage radiotherapy (SRT) is a longtime remedy for males with biochemical recurrence following radical prostatectomy (RP). There are a number of danger elements related to antagonistic outcomes; nevertheless, the worth of postoperative prostate-specific antigen (PSA) kinetics is much less clear within the ultrasensitive PSA period.
Goal: To characterize the impression of PSA kinetics on outcomes following SRT and generate nomograms to help in figuring out sufferers with an elevated danger of antagonistic scientific outcomes.
Design, setting, and individuals: A multi-institutional evaluation was carried out of 1005 sufferers with prostate most cancers handled with SRT after RP, with a median follow-up of 5 years.
Final result measurements and statistical evaluation: Variables examined embrace instant postoperative PSA, postoperative PSA doubling time (DT), and pre-SRT PSA, along with beforehand recognized predictive elements. Multivariable survival analyses have been accomplished utilizing High quality-Grey competing danger regression. Charges of biochemical failure (BF), distant metastasis (DM), and prostate cancer-specific mortality (PCSM) have been estimated by the cumulative incidence methodology. Nomograms have been generated from multivariable competing danger regression with bootstrap cross-validation.
Outcomes and limitations: Elements related to BF after SRT embrace PSA DT <6 mo, preliminary postoperative PSA ≥0.2 ng/ml, greater pre-SRT PSA, lack of androgen deprivation remedy, a better Gleason rating (GS), detrimental margins, seminal vesicle invasion, lack of pelvic nodal radiation, radiation complete dose <66 Gy, an extended RP to SRT interval, and older age (p < 0.05 for every). Elements related to DM embrace PSA DT <6 mo, pre-SRT PSA, a better GS, and detrimental margins. Elements related to PCSM embrace PSA DT not calculable or <6 mo and a better GS. Nomograms have been generated to estimate the dangers of BF (concordance index [CI] 0.74), DM (CI 0.77), and PCSM (CI 0.77). Limitations embrace retrospective nature, broad remedy eras, institutional variations, and a number of strategies out there for the estimation of PSA DT.
Conclusions: Postoperative PSA kinetics, significantly pre-SRT PSA and PSA DT, are strongly related to antagonistic oncologic outcomes following SRT and ought to be thought-about in administration selections.
Affected person abstract: On this report of males with prostate most cancers who developed a prostate-specific antigen (PSA) recurrence after prostatectomy, we discovered that PSA ranges after surgical procedure and the way shortly a PSA stage doubles considerably impression the possibility of prostate most cancers recurrence after salvage radiation remedy. Based mostly on this data, we created a device to calculate a person’s probability of most cancers recurrence after salvage radiation remedy, and these estimations can be utilized to debate whether or not extra remedy with radiation ought to be thought-about.
 Recombinant mouse Prostate stem cell antigen |
|||
| MBS9422457-002mg | MyBiosource | 0.02mg | EUR 380 |
Recombinant mouse Prostate stem cell antigen |
|||
| MBS9422457-01mg | MyBiosource | 0.1mg | EUR 650 |
Recombinant mouse Prostate stem cell antigen |
|||
| MBS9422457-05mg | MyBiosource | 0.5mg | EUR 1655 |
Recombinant mouse Prostate stem cell antigen |
|||
| MBS9422457-5x05mg | MyBiosource | 5x0.5mg | EUR 7290 |
 Mouse Prostate Stem Cell Antigen ELISA Kit |
|||
| MBS057229-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 6725 |
Mouse Prostate Stem Cell Antigen ELISA Kit |
|||
| MBS057229-48StripWells | MyBiosource | 48-Strip-Wells | EUR 550 |
Mouse Prostate Stem Cell Antigen ELISA Kit |
|||
| MBS057229-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 3420 |
Mouse Prostate Stem Cell Antigen ELISA Kit |
|||
| MBS057229-96StripWells | MyBiosource | 96-Strip-Wells | EUR 765 |
 Mouse Prostate stem cell antigen ELISA Kit |
|||
| MBS289860-10x96StripWells | MyBiosource | 10x96-Strip-Wells | EUR 4630 |
Mouse Prostate stem cell antigen ELISA Kit |
|||
| MBS289860-48StripWells | MyBiosource | 48-Strip-Wells | EUR 440 |
Mouse Prostate stem cell antigen ELISA Kit |
|||
| MBS289860-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 2480 |
Mouse Prostate stem cell antigen ELISA Kit |
|||
| MBS289860-96StripWells | MyBiosource | 96-Strip-Wells | EUR 580 |
) Recombinant Mouse Prostate stem cell antigen(Psca) |
|||
| AP72740 | SAB | each | Ask for price |
) Recombinant Mouse Prostate stem cell antigen (Psca) |
|||
| CSB-YP018840MO | Cusabio | 5939 mg | Ask for price |
Recombinant Mouse Prostate stem cell antigen (Psca) |
|||
| CSB-YP018840MO-20ug | Cusabio | 20ug | Ask for price |
|
Description: 21-95aa |
|||
Recombinant Mouse Prostate stem cell antigen (Psca) |
|||
| MBS962351-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 320 |
Recombinant Mouse Prostate stem cell antigen (Psca) |
|||
| MBS962351-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 515 |
Recombinant Mouse Prostate stem cell antigen (Psca) |
|||
| MBS962351-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1260 |
Recombinant Mouse Prostate stem cell antigen (Psca) |
|||
| MBS962351-5x05mgYeast | MyBiosource | 5x0.5mg(Yeast) | EUR 5485 |
Recombinant Mouse Prostate stem cell antigen (Psca) |
|||
| RPC20241-100ug | Biomatik Corporation | 100ug | EUR 569.8 |
Recombinant Mouse Prostate stem cell antigen (Psca) |
|||
| RPC20241-20ug | Biomatik Corporation | 20ug | EUR 353.4 |
) StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
|||
| CBA-325 | Cell Biolabs | 96 assays | EUR 1027.2 |
|
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
|||
StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
|||
| CBA-325-5 | Cell Biolabs | 5 x 96 assays | EUR 4033.2 |
|
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
|||
) HESCA-1 (Human Embryonic Stem Cell Antigen-1) |
|||
| MBS604449-01mg | MyBiosource | 0.1mg | EUR 785 |
HESCA-1 (Human Embryonic Stem Cell Antigen-1) |
|||
| MBS604449-5x01mg | MyBiosource | 5x0.1mg | EUR 3385 |
 ELISA Kit for Mouse Prostate stem cell antigen |
|||
| E8693m | EIAab | 96T | EUR 441.6 |
 ELISA Kit) Mouse Prostate stem cell antigen (PSCA) ELISA Kit |
|||
| abx520719-96tests | Abbexa | 96 tests | EUR 687.5 |
 Mouse Psca/ Prostate stem cell antigen ELISA Kit |
|||
| E1215Mo | Sunlong | 1 Kit | EUR 543 |
 Mouse Prostate stem cell antigen, Psca ELISA KIT |
|||
| ELI-22375m | Lifescience Market | 96 Tests | EUR 1038 |
Mouse Prostate stem cell antigen (PSCA) ELISA Kit |
|||
| RK13577 | Abclonal | 96T | EUR 322.37 |
 LY6E/Stem cell antigen 1 Polyclonal Antibody |
|||
| MBS9236660-01mL | MyBiosource | 0.1mL | EUR 415 |
LY6E/Stem cell antigen 1 Polyclonal Antibody |
|||
| MBS9236660-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
 StemTAG PCR Primer Set for Stem Cell Characterization |
|||
| CBA-303 | Cell Biolabs | 1 kit | EUR 470.4 |
|
Description: StemTAG PCR Primer Set for Stem Cell Characterization includes 7 primer pairs: Oct-4, NANOG, AFP, Flk-1, and NCAM, plus GAPDH and beta-actin as controls. |
|||
 Prostate stem cell antigen |
|||
| AP86675 | SAB | 1mg | EUR 2640 |
Prostate stem cell antigen |
|||
| AP87071 | SAB | 1mg | EUR 2640 |
) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) |
|||
| MBS630318-01mg | MyBiosource | 0.1mg | EUR 665 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) |
|||
| MBS630318-5x01mg | MyBiosource | 5x0.1mg | EUR 2850 |
 Total Protein - Murine Embryonic Stem Cell Line D3 |
|||
| CBA-305 | Cell Biolabs | 500 ?g | EUR 414 |
|
Description:
|
|||
 OPCA01291-20UG - Recombinant Mouse Prostate stem cell antigen |
|||
| OPCA01291-20UG | Aviva Systems Biology | 20ug | EUR 315 |
 OPCA01291-100UG - Recombinant Mouse Prostate stem cell antigen |
|||
| OPCA01291-100UG | Aviva Systems Biology | 100ug | EUR 462 |
 OPCA01291-500UG - Recombinant Mouse Prostate stem cell antigen |
|||
| OPCA01291-500UG | Aviva Systems Biology | 500ug | EUR 1276 |
 (AP)) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (AP) |
|||
| MBS6485594-01mL | MyBiosource | 0.1mL | EUR 920 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (AP) |
|||
| MBS6485594-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
 APC) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) APC |
|||
| MBS6485595-01mL | MyBiosource | 0.1mL | EUR 920 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) APC |
|||
| MBS6485595-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
 (FITC)) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (FITC) |
|||
| MBS6485597-01mL | MyBiosource | 0.1mL | EUR 920 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (FITC) |
|||
| MBS6485597-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
 (HRP)) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (HRP) |
|||
| MBS6485598-01mL | MyBiosource | 0.1mL | EUR 920 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (HRP) |
|||
| MBS6485598-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
 (PE)) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (PE) |
|||
| MBS6485604-01mL | MyBiosource | 0.1mL | EUR 920 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (PE) |
|||
| MBS6485604-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
 - Mouse prostate stem cell antigen (Psca), (10ug)) Psca (untagged) - Mouse prostate stem cell antigen (Psca), (10ug) |
|||
| MC211324 | Origene Technologies GmbH | 10 µg | Ask for price |
 (Biotin)) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (Biotin) |
|||
| MBS6485596-01mL | MyBiosource | 0.1mL | EUR 920 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (Biotin) |
|||
| MBS6485596-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
 (MaxLight 405)) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (MaxLight 405) |
|||
| MBS6485599-01mL | MyBiosource | 0.1mL | EUR 920 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (MaxLight 405) |
|||
| MBS6485599-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
 (MaxLight 490)) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (MaxLight 490) |
|||
| MBS6485600-01mL | MyBiosource | 0.1mL | EUR 920 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (MaxLight 490) |
|||
| MBS6485600-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
 (MaxLight 550)) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (MaxLight 550) |
|||
| MBS6485601-01mL | MyBiosource | 0.1mL | EUR 920 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (MaxLight 550) |
|||
| MBS6485601-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
 (MaxLight 650)) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (MaxLight 650) |
|||
| MBS6485602-01mL | MyBiosource | 0.1mL | EUR 920 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (MaxLight 650) |
|||
| MBS6485602-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
 (MaxLight 750)) LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (MaxLight 750) |
|||
| MBS6485603-01mL | MyBiosource | 0.1mL | EUR 920 |
LY6E (Lymphocyte Antigen 6E, Ly-6E, Retinoic Acid-induced Gene E Protein, RIG-E, Stem Cell Antigen 2, SCA-2, Thymic Shared Antigen 1, TSA-1, 9804, RIGE, SCA2, TSA1) (MaxLight 750) |
|||
| MBS6485603-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
 ELISA Kit) CytoSelect Proliferating Cell Nuclear Antigen (PCNA) ELISA Kit |
|||
| CBA-254 | Cell Biolabs | 96 assays | EUR 672 |
|
Description: Cell Biolabs? CytoSelect Proliferating Cell Nuclear Antigen (PCNA) ELISA Kit is an enzyme immunoassay developed for the detection and quantitation of PCNA from nuclear and whole cell extracts. The kit detects PCNA from mouse, rat and human, and has a detection sensitivity limit of 12.5 ng/mLPCNA. Each kit provides sufficient reagents to perform up to 96 assays including standard curve and unknown samples. |
|||
 - Mouse prostate stem cell antigen (Psca), (10ug)) Psca (GFP-tagged) - Mouse prostate stem cell antigen (Psca), (10ug) |
|||
| MG215317 | Origene Technologies GmbH | 10 µg | Ask for price |
 - Mouse prostate stem cell antigen (Psca)) Psca (Myc-DDK-tagged) - Mouse prostate stem cell antigen (Psca) |
|||
| MR215317 | Origene Technologies GmbH | 10 µg | Ask for price |
 Prostate Stem Cell Antigen Antibody |
|||
| ABD8709 | Lifescience Market | 100 ug | EUR 525.6 |
Prostate Stem Cell Antigen Antibody |
|||
| 8C0310 | AAT Bioquest | 50ug | EUR 368 |
|
Description: Prostate Stem Cell Antigen Antibody |
|||
Prostate Stem Cell Antigen Antibody |
|||
| 33476 | SAB | 100ul | EUR 319 |
Prostate Stem Cell Antigen Antibody |
|||
| 33476-100ul | SAB | 100ul | EUR 302.4 |
Prostate Stem Cell Antigen Antibody |
|||
| 33476-50ul | SAB | 50ul | EUR 224.4 |
Prostate Stem Cell Antigen Antibody |
|||
| DF8709 | Affbiotech | 200ul | EUR 420 |
Prostate Stem Cell Antigen Antibody |
|||
| DF8709-100ul | Affinity Biosciences | 100ul | EUR 168 |
|
Description: WB,IF/ICC,ELISA(peptide) |
|||
Prostate Stem Cell Antigen Antibody |
|||
| DF8709-200ul | Affinity Biosciences | 200ul | EUR 210 |
|
Description: WB,IF/ICC,ELISA(peptide) |
|||
Prostate Stem Cell Antigen Antibody |
|||
| E033476 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
Prostate Stem Cell Antigen Antibody |
|||
| E11-0310C | EnoGene | 100μg/100μl | EUR 225 |
|
Description: Available in various conjugation types. |
|||
Prostate Stem Cell Antigen Antibody |
|||
| E19-8709-1 | EnoGene | 50ug/50ul | EUR 145 |
|
Description: Available in various conjugation types. |
|||
Prostate Stem Cell Antigen Antibody |
|||
| E19-8709-2 | EnoGene | 100ug/100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
Prostate Stem Cell Antigen Antibody |
|||
| MBS853379-01mg | MyBiosource | 0.1mg | EUR 305 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS853379-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS853379-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS853379-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS853379-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS8532743-005mg | MyBiosource | 0.05mg | EUR 235 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS8532743-01mg | MyBiosource | 0.1mg | EUR 305 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS8532743-01mLAF405M | MyBiosource | 0.1mL(AF405M) | EUR 465 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS8532743-01mLAF546 | MyBiosource | 0.1mL(AF546) | EUR 465 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS8532743-01mLAF750 | MyBiosource | 0.1mL(AF750) | EUR 465 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9400891-005mL | MyBiosource | 0.05mL | EUR 245 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9400891-01mL | MyBiosource | 0.1mL | EUR 305 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9400891-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9504710-005mL | MyBiosource | 0.05mL | EUR 285 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9504710-01mL | MyBiosource | 0.1mL | EUR 385 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9504710-5x01mL | MyBiosource | 5x0.1mL | EUR 1590 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9510061-005mL | MyBiosource | 0.05mL | EUR 285 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9510061-01mL | MyBiosource | 0.1mL | EUR 385 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9510061-5x01mL | MyBiosource | 5x0.1mL | EUR 1590 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9609026-01mL | MyBiosource | 0.1mL | EUR 260 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9609026-02mL | MyBiosource | 0.2mL | EUR 305 |
Prostate Stem Cell Antigen Antibody |
|||
| MBS9609026-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
 Recombinant Mouse Prostate stem cell antigen Protein, His, Yeast-1mg |
|||
| QP9353-ye-1mg | EnQuireBio | 1mg | EUR 2763.6 |
Proposed Framework for Contemplating SARS-CoV-2 Antigen Testing of Unexposed Asymptomatic Staff in Chosen Workplaces
asymptomatic staff in chosen workplaces.
Strategies: This can be a commentary based mostly on established occupational security and well being rules, revealed articles, and different pertinent literature, together with non-peer-reviewed preprints in medrixiv.org previous to April 16, 2021.
Outcomes: Not relevant to this commentary/viewpoint article.
Conclusion: Antigen testing is a quickly evolving and helpful public well being device that can be utilized to information measures to cut back unfold of SARS-CoV-2 in the neighborhood and in chosen workplaces. This commentary supplies a proposed framework for occupational security and well being practitioners and employers for contemplating antigen testing as a way to display asymptomatic staff in chosen non-healthcare settings. When utilized selectively, antigen testing could be a helpful, efficient a part of a complete office program for COVID-19 prevention and management.
Affiliation of single-nucleotide polymorphisms in tumour necrosis issue and human leukocyte antigens genes with sort 1 diabetes
Kind 1 diabetes (T1D) is an autoimmune illness characterised by progressive destruction of insulin-producing pancreatic beta cells. This multifactorial illness has a sturdy genetic part related to the human leukocyte antigens (HLA) and non-HLA areas. On this research, we in contrast frequencies of HLA-DRB1 alleles and single-nucleotide polymorphisms (SNPs) related the genes coding for: toll-like receptors (TLRs), tumour necrosis issue (TNF), interleukin-1 (IL-1), interleukin-1 receptor sort 1 (IL-1R1), interleukin-1 receptor antagonist (IL-1RN), interleukin-2 (IL-2) and interleukin-12B (IL-12B), between T1D sufferers and wholesome controls.
The intention was to establish frequency variations and linkage between these genetic markers in T1D sufferers and wholesome controls. Twelve SNPs have been investigated as follows: rs16944 (IL-1B), rs1143634 (IL-1B), rs1800587 (IL-1A), rs2069762 (IL-2), rs3212227 (IL-12B), rs2234650 (IL-1R1), rs315952 (IL-1RN), rs3804099 (TLR2), rs4986790 (TLR4), rs4986791 (TLR4), rs1800629 (TNF) and rs361525 (TNF). TaqMan genotype assay methodology was used for SNPs genotyping. HLA-DRB1* genes have been typed by Sequence Particular Oligonucleotide Probe (SSOP). SPSS and SNPStats packages have been used for the statistical evaluation. Vital variations between T1D and management teams have been discovered for the dominant mannequin of rs361525 and rs1800629A:rs361525G genotypes for TNF.
Elevated frequencies of DRB1*03 and DRB1*04 and decreased frequencies of DRB1*07, DRB1*11 and DRB1*13 and DRB1*15 have been noticed in T1D sufferers in contrast with controls. Nonetheless, the genotype, DRB1*07 with rs1800629A/G was related to T1D. Now we have confirmed that DRB1*03 and DRB1*04 are related to elevated danger and DRB1*07, DRB1*11 and DRB1*13 and DRB1*15 with decreased danger of T1D. Additionally, the dominant mannequin of rs361525A, and the rs1800629G:361525A genotype have been related to elevated danger. The simultaneous presence of DRB1*07 and rs1800629A/G genotypes in 23 out of 27 DRB1*07 optimistic T1D sufferers implied that islet cell peptide processing could have been biased in direction of autoimmunity by upregulation of TNF related intronic SNPs.
Are chimeric antigen receptor T cells (CAR-T cells) the long run in immunotherapy for autoimmune illnesses?
Goal: CAR-T cell remedy has revolutionized the remedy of oncological illnesses, and potential makes use of in autoimmune illnesses have lately been described. The assessment goals to combine the out there knowledge on remedy with CAR-T cells, emphasizing autoimmune illnesses, to find out therapeutic advances and their doable future scientific applicability in autoimmunity.
Supplies and strategies: A search was carried out in PubMed with the key phrases “Chimeric Antigen Receptor” and “CART cell”. The paperwork of curiosity have been chosen, and a vital assessment of the data was carried out.
Outcomes: Within the remedy of autoimmune illnesses, in preclinical fashions, three totally different mobile methods have been used, which embrace Chimeric antigen receptor T cells, Chimeric autoantibody receptor T cells, and Chimeric antigen receptor in regulatory T lymphocytes. All three varieties of remedy have been efficient. The potential antagonistic results inside them, cytokine launch syndrome, mobile toxicity and neurotoxicity should at all times be saved in thoughts.
Conclusions: Though data in people will not be but out there, preclinical fashions of CAR-T cells within the remedy of autoimmune illnesses present promising outcomes, in order that sooner or later, they might develop into a helpful and efficient remedy within the remedy of those pathologies.
 Monoclonal antibody, clone MECA-32) Rat Anti-Mouse Pan-endothelial Cell Antigen (MECA-32) Monoclonal antibody, clone MECA-32 |
|||
| CABT-L4470-1mg | Creative Diagnostics | 1 mg | EUR 1076.4 |
Rat Anti-Mouse Pan-endothelial Cell Antigen (MECA-32) Monoclonal antibody, clone MECA-32 |
|||
| CABT-L4470-5mg | Creative Diagnostics | 5 mg | EUR 2886 |
 Antibody) Anti-Murine Panendothelial Cell Antigen (MECA-32) Antibody |
|||
| MBS4158532-01mg | MyBiosource | 0.1mg | EUR 920 |
Anti-Murine Panendothelial Cell Antigen (MECA-32) Antibody |
|||
| MBS4158532-5x01mg | MyBiosource | 5x0.1mg | EUR 3880 |
) Mouse Anti-Hepatitis B Surface Antigen Antibody (1834) |
|||
| MAB12230-100 | The Native Antigen Company | 0.1 | EUR 278.11 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1834). |
|||
) Mouse Anti-Hepatitis B Surface Antigen Antibody (1837) |
|||
| MAB12231-100 | The Native Antigen Company | 0.1 | EUR 278.11 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1837) |
|||
) Mouse Anti-Hepatitis B Surface Antigen Antibody (1838) |
|||
| MAB12232-100 | The Native Antigen Company | 0.1 | EUR 278.11 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1838) |
|||
) Mouse Anti-Hepatitis B Virus E Antigen Antibody (1892) |
|||
| MAB12226-100 | The Native Antigen Company | 0.1 | EUR 198.28 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1892) |
|||
) Mouse Anti-Hepatitis B Virus E Antigen Antibody (1893) |
|||
| MAB12227-100 | The Native Antigen Company | 0.1 | EUR 278.11 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1893) |
|||
) Mouse Anti-Hepatitis B Virus E Antigen Antibody (1894) |
|||
| MAB12228-100 | The Native Antigen Company | 0.1 | EUR 278.11 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1894) |
|||
) Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132) |
|||
| MAB12298-100 | The Native Antigen Company | 0.1 | EUR 279.4 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132) |
|||
| MAB12298-500 | The Native Antigen Company | 0.5 | EUR 701.72 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132) |
|||
) Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133) |
|||
| MAB12299-100 | The Native Antigen Company | 0.1 | EUR 279.4 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133) |
|||
| MAB12299-500 | The Native Antigen Company | 0.5 | EUR 701.72 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133) |
|||
 (PE)) PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (PE) |
|||
| MBS6252121-01mL | MyBiosource | 0.1(mL | EUR 860 |
PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (PE) |
|||
| MBS6252121-5x01mL | MyBiosource | 5x0.1mL | EUR 3720 |
 (HRP)) PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (HRP) |
|||
| MBS6251180-01mL | MyBiosource | 0.1(mL | EUR 860 |
PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (HRP) |
|||
| MBS6251180-5x01mL | MyBiosource | 5x0.1mL | EUR 3720 |
 (AP)) PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (AP) |
|||
| MBS6248246-01mL | MyBiosource | 0.1(mL | EUR 860 |
PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (AP) |
|||
| MBS6248246-5x01mL | MyBiosource | 5x0.1mL | EUR 3720 |
 (FITC)) PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (FITC) |
|||
| MBS6250161-01mL | MyBiosource | 0.1(mL | EUR 860 |
PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (FITC) |
|||
| MBS6250161-5x01mL | MyBiosource | 5x0.1mL | EUR 3720 |
 (APC)) PLVAPC (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (APC) |
|||
| MBS6269097-01mL | MyBiosource | 0.1mL | EUR 860 |
PLVAPC (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (APC) |
|||
| MBS6269097-5x01mL | MyBiosource | 5x0.1mL | EUR 3720 |
 (MaxLight 405)) PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (MaxLight 405) |
|||
| MBS6253154-01mL | MyBiosource | 0.1(mL | EUR 860 |
PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (MaxLight 405) |
|||
| MBS6253154-5x01mL | MyBiosource | 5x0.1mL | EUR 3720 |
 (MaxLight 490)) PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (MaxLight 490) |
|||
| MBS6254194-01mL | MyBiosource | 0.1(mL | EUR 860 |
PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (MaxLight 490) |
|||
| MBS6254194-5x01mL | MyBiosource | 5x0.1mL | EUR 3720 |
 (MaxLight 550)) PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (MaxLight 550) |
|||
| MBS6255234-01mL | MyBiosource | 0.1(mL | EUR 860 |
PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (MaxLight 550) |
|||
| MBS6255234-5x01mL | MyBiosource | 5x0.1mL | EUR 3720 |
 (MaxLight 650)) PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (MaxLight 650) |
|||
| MBS6256274-01mL | MyBiosource | 0.1(mL | EUR 860 |
PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (MaxLight 650) |
|||
| MBS6256274-5x01mL | MyBiosource | 5x0.1mL | EUR 3720 |
 (MaxLight 750)) PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (MaxLight 750) |
|||
| MBS6257313-01mL | MyBiosource | 0.1mL | EUR 860 |
PLVAP (Plasmalemma Vesicle-Associated Protein, Plasmalemma Vesicle Protein 1, PV-1, MECA-32 Antigen, Pv1) (MaxLight 750) |
|||
| MBS6257313-5x01mL | MyBiosource | 5x0.1mL | EUR 3720 |
) Anti-Mouse MAdCAM-1 In Vivo Antibody (MECA-89) |
|||
| ICH1214-100mg | ichorbio | 100mg | EUR 2830 |
|
Description: MAdCAM-1 |
|||
Anti-Mouse MAdCAM-1 In Vivo Antibody (MECA-89) |
|||
| ICH1214-25mg | ichorbio | 25mg | EUR 1260 |
|
Description: MAdCAM-1 |
|||
Anti-Mouse MAdCAM-1 In Vivo Antibody (MECA-89) |
|||
| ICH1214-50mg | ichorbio | 50mg | EUR 2010 |
|
Description: MAdCAM-1 |
|||
Anti-Mouse MAdCAM-1 In Vivo Antibody (MECA-89) |
|||
| ICH1214-5mg | ichorbio | 5mg | EUR 380 |
|
Description: MAdCAM-1 |
|||
 Rat Anti-Mouse MAdCAM-1 Monoclonal antibody, clone MECA-367 |
|||
| CABT-L4373 | Creative Diagnostics | 1 mg; 5 mg | Ask for price |
|
Description: Rat |
|||
Rat Anti-Mouse MAdCAM-1 Monoclonal antibody, clone MECA-367 |
|||
| CABT-L4373-1mg | Creative Diagnostics | 1 mg | EUR 1076.4 |
Rat Anti-Mouse MAdCAM-1 Monoclonal antibody, clone MECA-367 |
|||
| CABT-L4373-5mg | Creative Diagnostics | 5 mg | EUR 2886 |
 Borrelia Afzelii Antigen |
|||
| NAT41583-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Borrelia Afzelii Antigen |
|||
| NAT41583-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
 Borrelia Garinii Antigen |
|||
| NAT41584-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Borrelia Garinii Antigen |
|||
| NAT41584-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
 Brucella Abortus Antigen |
|||
| NAT41599-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Brucella abortus lysate, produced by fermentation. |
|||
Brucella Abortus Antigen |
|||
| NAT41599-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Brucella abortus lysate, produced by fermentation. |
|||
 Candida Albicans Antigen |
|||
| NAT41601-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
|||
Candida Albicans Antigen |
|||
| NAT41601-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
|||
 Canine Parvovirus Antigen |
|||
| NAT41594-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Parvovirus, produced in CRFK cells. |
|||
 Canine Coronavirus Antigen |
|||
| NAT41590-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Coronavirus produced in A-72 cells. |
|||
 Feline Calicivirus Antigen |
|||
| NAT41595-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Feline Calicivirus produced in FC 3TG cells. |
|||
 Helicobacter Pylori Antigen |
|||
| NAT41603-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
|||
Helicobacter Pylori Antigen |
|||
| NAT41603-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
|||
 Campylobacter Jejuni Antigen |
|||
| NAT41600-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
|||
Campylobacter Jejuni Antigen |
|||
| NAT41600-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
|||
 Chlamydia Trachomatis Antigen |
|||
| CT022-1000 | The Native Antigen Company | 1.0 | EUR 382.41 |
|
Description: Chlamydia trachomatis antigens from clarified cell lysate. |
|||
 Mycoplasma Pneumoniae Antigen |
|||
| MP901-1000 | The Native Antigen Company | 1.0 | EUR 1019.75 |
|
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
|||
Mycoplasma Pneumoniae Antigen |
|||
| MP901-200 | The Native Antigen Company | 0.2 | EUR 272.96 |
|
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
|||
 Neisseria Gonorrhoeae Antigen |
|||
| NG01-1000 | The Native Antigen Company | 1.0 | EUR 382.41 |
|
Description: Homogenised lysate of pure bacteria. |
|||
 Echovirus Antigen, Recombinant |
|||
| REC31776-100 | The Native Antigen Company | 0.1 | EUR 279.4 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
|||
Echovirus Antigen, Recombinant |
|||
| REC31776-500 | The Native Antigen Company | 0.5 | EUR 1053.23 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
|||
 Trichomonas Vaginalis Antigen |
|||
| TV01-1000 | The Native Antigen Company | 1.0 | EUR 424.9 |
|
Description: Washed & lysed suspension of whole protozoa |
|||
 Echinococcus Granulosus Antigen |
|||
| NAT41602-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
|||
Echinococcus Granulosus Antigen |
|||
| NAT41602-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
|||
 Enterovirus Antigen, Recombinant |
|||
| REC31772-100 | The Native Antigen Company | 0.1 | EUR 279.4 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
|||
Enterovirus Antigen, Recombinant |
|||
| REC31772-500 | The Native Antigen Company | 0.5 | EUR 1053.23 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
|||
) Astrovirus Antigen (Type 1) |
|||
| AS02-1000 | The Native Antigen Company | 1.0 | EUR 1669.97 |
|
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
|||
Astrovirus Antigen (Type 1) |
|||
| AS02-200 | The Native Antigen Company | 0.2 | EUR 446.78 |
|
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
|||
 Yersinia pestis V antigen |
|||
| REC32028-100 | The Native Antigen Company | 0.1 | EUR 326.34 |
|
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
|||
Yersinia pestis V antigen |
|||
| REC32028-500 | The Native Antigen Company | 0.5 | EUR 1386.95 |
|
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
|||
 Cytomegalovirus Purified Antigen |
|||
| CMV-HP-100 | The Native Antigen Company | 0.1 | EUR 321.89 |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
Cytomegalovirus Purified Antigen |
|||
| CMV-HP-1000 | The Native Antigen Company | 1.0 | EUR 2115.47 |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
Cytomegalovirus Purified Antigen |
|||
| CMV-HP-500 | The Native Antigen Company | 0.5 | EUR 1291.43 |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
 Canine Herpes Virus Antigen |
|||
| NAT41592-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Herpes virus, produced in MDCK cells. |
|||
 Canine Adenovirus 1 Antigen |
|||
| NAT41587-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Adenovirus Type 1, produced in A-72 cells. |
|||
 Canine Adenovirus 2 Antigen |
|||
| NAT41588-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Adenovirus Type 2, produced in A-72 cells. |
|||
 Toxoplasma gondii IgM antigen |
|||
| TG-IgM-100 | The Native Antigen Company | 0.1mg | EUR 139.86 |
|
Description: A highly purified source of Toxoplasma gondii membrane antigens, optimised for IgM detection. |
|||
Toxoplasma gondii IgM antigen |
|||
| TG-IgM-1000 | The Native Antigen Company | 1.0mg | EUR 1189.51 |
|
Description: A highly purified source of Toxoplasma gondii membrane antigens, optimised for IgM detection. |
|||
 Canine Distemper Virus Antigen |
|||
| NAT41591-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Distemper virus, produced in SL-29 cells. |
|||
 Norovirus GII.4 VP1 Antigen |
|||
| REC31620-100 | The Native Antigen Company | 0.1 | EUR 305.15 |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
Norovirus GII.4 VP1 Antigen |
|||
| REC31620-1000 | The Native Antigen Company | 1.0 | EUR 1847.65 |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
Norovirus GII.4 VP1 Antigen |
|||
| REC31620-500 | The Native Antigen Company | 0.5 | EUR 1076.4 |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
 Canine Parainfluenza Virus Antigen |
|||
| NAT41593-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Parainfluenza virus antigen, produced in MDCK cells. |
|||
 Feline Panleukopenia Virus Antigen |
|||
| NAT41597-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Feline Panleukopenia Virus (FPLV; feline parvovirus) antigen, produced in CRFK cells. |
|||
 Cytomegalovirus Cell Lysate Antigen |
|||
| CMV-CL-100 | The Native Antigen Company | 0.1 | EUR 225.32 |
|
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
|||
Cytomegalovirus Cell Lysate Antigen |
|||
| CMV-CL-1000 | The Native Antigen Company | 1.0 | EUR 1435.63 |
|
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
|||
 Herpes Simplex Virus 1 Antigen |
|||
| HS105-1000 | The Native Antigen Company | 1.0 | EUR 1189.71 |
|
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Herpes Simplex Virus 1 Antigen |
|||
| HS105-200 | The Native Antigen Company | 0.2 | EUR 297.43 |
|
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
 Herpes Simplex Virus 2 Antigen |
|||
| HS205-1000 | The Native Antigen Company | 1.0 | EUR 1189.71 |
|
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Herpes Simplex Virus 2 Antigen |
|||
| HS205-200 | The Native Antigen Company | 0.2 | EUR 297.43 |
|
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
 Feline Viral Rhinotracheitis Antigen |
|||
| NAT41598-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Feline Viral Rhinotracheitis (FVR; feline herpes virus, FHV-1) antigen, produced in CRFK cells. |
|||
 Ross River Virus Recombinant Antigen |
|||
| REC31969-100 | The Native Antigen Company | 0.1 | EUR 764.81 |
|
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein. |
|||
Ross River Virus Recombinant Antigen |
|||
| REC31969-500 | The Native Antigen Company | 0.5 | EUR 2871.26 |
|
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein. |
|||
 Canine Adenovirus 1 and 2 Antigen |
|||
| NAT41589-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells. |
|||
) Hepatitis B Virus E Antigen (HBeAg) |
|||
| REC31677-100 | The Native Antigen Company | 0.1 | EUR 460.95 |
|
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
|||
Hepatitis B Virus E Antigen (HBeAg) |
|||
| REC31677-500 | The Native Antigen Company | 0.5 | EUR 1382.84 |
|
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
|||
) Hepatitis B Virus Core Antigen (HBcAg) |
|||
| REC31689-100 | The Native Antigen Company | 0.1 | EUR 460.95 |
|
Description: Recombinant Hepititis B Virus Core Protein (HBcAg). |
|||
Hepatitis B Virus Core Antigen (HBcAg) |
|||
| REC31689-500 | The Native Antigen Company | 0.5 | EUR 1382.84 |
|
Description: Recombinant Hepititis B Virus Core Protein (HBcAg). |
|||
) Hepatitis C Virus Core Antigen (HCcAg) |
|||
| REC31693-100 | The Native Antigen Company | 0.1 | EUR 489.27 |
|
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
|||
Hepatitis C Virus Core Antigen (HCcAg) |
|||
| REC31693-500 | The Native Antigen Company | 0.5 | EUR 1469.11 |
|
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
|||
 Herpes Simplex Virus 1 Lysate Antigen |
|||
| HS104-1000 | The Native Antigen Company | 1.0 | EUR 272.96 |
|
Description: A high concentration of HSV-1 particles and proteins from a clarified cell lysate. |
|||
 Herpes Simplex Virus 2 Lysate Antigen |
|||
| HS204-1000 | The Native Antigen Company | 1.0 | EUR 272.96 |
|
Description: A high concentration of HSV-2 particles and proteins from a clarified cell lysate. |
|||
 Feline Infectious Peritonitis Virus Antigen |
|||
| NAT41596-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Feline Infectious Peritonitis virus (FIPV; feline coronavirus) antigen, produced in CRFK cells. |
|||
 Toxoplasma gondii IgG antigen, RH strain |
|||
| TG-IgG-1000 | The Native Antigen Company | 1.0 mg | EUR 338 |
|
Description: A concentrated source of Toxoplasma gondii tachyzoite antigens, optimised for IgG detection, diluted to 0.5 mg/ml. |
|||
Toxoplasma gondii IgG antigen, RH strain |
|||
| TG-IgG-200 | The Native Antigen Company | 0.2 mg | EUR 174.83 |
|
Description: A concentrated source of Toxoplasma gondii tachyzoite antigens, optimised for IgG detection, diluted to 0.5 mg/ml. |
|||
Toxoplasma gondii IgG antigen, RH strain |
|||
| TG-IgG-5000 | The Native Antigen Company | 5.0 mg | EUR 1436.48 |
|
Description: A concentrated source of Toxoplasma gondii tachyzoite antigens, optimised for IgG detection, diluted to 0.5 mg/ml. |
|||
) Legionella pneumophila antigen (native extract) |
|||
| NAT41580-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Inactivated Legionella pneumophila antigen from culture. |
|||
) Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
| NAT41582-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
|||
Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
| NAT41582-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
|||
 Streptococcus Pneumoniae Antigen, Native Extract |
|||
| NAT41604-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Inactivated Streptococcus pneumoniae antigen from culture. |
|||
) Mouse Anti-Giardia Monoclonal Antibody (E4) |
|||
| MAB12477-100 | The Native Antigen Company | 0.1 | EUR 399.14 |
|
Description: This antibody recognises the Cyst-Wall-Protein-1 (CWP1) antigen on the surface of Giardia cysts. |
|||
Mouse Anti-Giardia Monoclonal Antibody (E4) |
|||
| MAB12477-500 | The Native Antigen Company | 0.5 | EUR 1694.43 |
|
Description: This antibody recognises the Cyst-Wall-Protein-1 (CWP1) antigen on the surface of Giardia cysts. |
|||
) Mouse Anti-Giardia Monoclonal Antibody (E11) |
|||
| MAB12478-100 | The Native Antigen Company | 0.1 | EUR 399.14 |
|
Description: This antibody recognises the Cyst-Wall-Protein-1 (CWP1) antigen on the surface of Giardia cysts. |
|||
Mouse Anti-Giardia Monoclonal Antibody (E11) |
|||
| MAB12478-500 | The Native Antigen Company | 0.5 | EUR 1694.43 |
|
Description: This antibody recognises the Cyst-Wall-Protein-1 (CWP1) antigen on the surface of Giardia cysts. |
|||
) Mouse Anti-Giardia Monoclonal Antibody (G203) |
|||
| MAB12479-100 | The Native Antigen Company | 0.1 | EUR 399.14 |
|
Description: This antibody recognises the Cyst-Wall-Protein-1 (CWP1) antigen on the surface of Giardia cysts. |
|||
Mouse Anti-Giardia Monoclonal Antibody (G203) |
|||
| MAB12479-500 | The Native Antigen Company | 0.5 | EUR 1694.43 |
|
Description: This antibody recognises the Cyst-Wall-Protein-1 (CWP1) antigen on the surface of Giardia cysts. |
|||
 MOUSE ANTI MOUSE NK-1.1 ANTIGEN |
|||
| MBS212065-025mg | MyBiosource | 0.25mg | EUR 500 |
MOUSE ANTI MOUSE NK-1.1 ANTIGEN |
|||
| MBS212065-5x025mg | MyBiosource | 5x0.25mg | EUR 2070 |
 Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag |
|||
| REC32027-100 | The Native Antigen Company | 0.1 | EUR 326.34 |
|
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1) |
|||
Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag |
|||
| REC32027-500 | The Native Antigen Company | 0.5 | EUR 1386.95 |
|
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1) |
|||
) Mouse Anti-Giardia Lamblia Trophozoite Antibody (G18) |
|||
| MAB12153-100 | The Native Antigen Company | 0.1 | EUR 307.91 |
|
Description: Mouse monoclonal antibody specific for Giardia lamblia trophoziote protein (clone G18) |
|||
) Mouse Anti-Giardia Lamblia Trophozoite Antibody (G22) |
|||
| MAB12154-100 | The Native Antigen Company | 0.1 | EUR 307.91 |
|
Description: Mouse monoclonal antibody specific for Giardia lamblia trophoziote protein (clone G22) |
|||
) Mouse Anti-Hepatitis D Antigen (Delta Virus Antigen) |
|||
| MBS6506734-1mg | MyBiosource | 1mg | EUR 785 |
Mouse Anti-Hepatitis D Antigen (Delta Virus Antigen) |
|||
| MBS6506734-5x1mg | MyBiosource | 5x1mg | EUR 3305 |
 Anti-La Antigen Mouse mAb |
|||
| MBS475587-01mL | MyBiosource | 0.1mL | EUR 450 |
Anti-La Antigen Mouse mAb |
|||
| MBS475587-5x01mL | MyBiosource | 5x0.1mL | EUR 1540 |
Anti-La Antigen Mouse mAb |
|||
| MBS8533223-01mL | MyBiosource | 0.1mL | EUR 305 |
Anti-La Antigen Mouse mAb |
|||
| MBS8533223-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
Anti-La Antigen Mouse mAb |
|||
| MBS8533223-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
Anti-La Antigen Mouse mAb |
|||
| MBS8533223-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
Anti-La Antigen Mouse mAb |
|||
| MBS8533223-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
 MOUSE ANTI HUMAN NUCLEAR ANTIGEN |
|||
| MBS211180-01mL | MyBiosource | 0.1mL | EUR 605 |
MOUSE ANTI HUMAN NUCLEAR ANTIGEN |
|||
| MBS211180-5x01mL | MyBiosource | 5x0.1mL | EUR 2555 |
 Mouse anti Carcinoma ass. Antigen |
|||
| MBS570279-01mg | MyBiosource | 0.1mg | EUR 515 |
Mouse anti Carcinoma ass. Antigen |
|||
| MBS570279-5x01mg | MyBiosource | 5x0.1mg | EUR 2165 |
 PLVAP rat monoclonal antibody, clone MECA-32, Biotin |
|||
| AM05595BT-N | Origene Technologies GmbH | 100 µg | Ask for price |
 PLVAP rat monoclonal antibody, clone MECA-32, Purified |
|||
| AM05595PU-L | Origene Technologies GmbH | 250 µg | Ask for price |
PLVAP rat monoclonal antibody, clone MECA-32, Purified |
|||
| AM05595PU-N | Origene Technologies GmbH | 100 µg | Ask for price |
PLVAP rat monoclonal antibody, clone MECA-32, Purified |
|||
| AM05595PU-T | Origene Technologies GmbH | 25 µg | Ask for price |
 MOUSE ANTI ANTHRAX PROTECTIVE ANTIGEN |
|||
| MBS214545-02mg | MyBiosource | 0.2mg | EUR 515 |
MOUSE ANTI ANTHRAX PROTECTIVE ANTIGEN |
|||
| MBS214545-5x02mg | MyBiosource | 5x0.2mg | EUR 2145 |
, 1mg/mL) MECA-79(MECA-79), 1mg/mL |
|||
| BNUM1599-50 | Biotium | 1uL | EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
, 0.2mg/mL) MECA-79(MECA-79), 0.2mg/mL |
|||
| BNUB1599-100 | Biotium | 1uL | EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MECA-79(MECA-79), 0.2mg/mL |
|||
| BNUB1599-500 | Biotium | 1uL | EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
) Mouse Anti-Adenovirus Antibody (A68) |
|||
| MAB12508-100 | The Native Antigen Company | 0.1 | EUR 278.11 |
|
Description: Mouse monoclonal antibody specific for Adenovirus (clone A68). |
|||
Mouse Anti-Adenovirus Antibody (A68) |
|||
| MAB12508-500 | The Native Antigen Company | 0.5 | EUR 973.4 |
|
Description: Mouse monoclonal antibody specific for Adenovirus (clone A68). |
|||
) Mouse Anti-Adenovirus Antibody (A93) |
|||
| MAB12509-100 | The Native Antigen Company | 0.1 | EUR 278.11 |
|
Description: Mouse monoclonal antibody specific for Adenovirus (clone A93). |
|||
Mouse Anti-Adenovirus Antibody (A93) |
|||
| MAB12509-500 | The Native Antigen Company | 0.5 | EUR 973.4 |
|
Description: Mouse monoclonal antibody specific for Adenovirus (clone A93). |
|||
 Mouse anti Melanoma Associated Antigen |
|||
| MBS570200-01mg | MyBiosource | 0.1mg | EUR 515 |
Mouse anti Melanoma Associated Antigen |
|||
| MBS570200-5x01mg | MyBiosource | 5x0.1mg | EUR 2165 |
Mouse anti Melanoma Associated Antigen |
|||
| MBS570274-01mg | MyBiosource | 0.1mg | EUR 515 |
Mouse anti Melanoma Associated Antigen |
|||
| MBS570274-5x01mg | MyBiosource | 5x0.1mg | EUR 2165 |
